I think the issue with CUV is the fact that since the approval there has been a massive lack of communication. There are issues around not approval but reimbursement being approced in certain areas in europe. This has severely limited the revenue.
could msb share a similar fate? Not only in certain countries or Insurance funds not agreeing to reimburse the treatment but could there be issues with getting doctors on board to prescribe it? I read a post here a couple months ago suggesting someone had spoken to a group of doctors who didn't believe stem cell therapy works. While we know it does and the trials show that, could we have a hard time convincing the medical professionals to use it?
- Forums
- ASX - By Stock
- MSB
- MSB Trading - 2020
MSB Trading - 2020, page-323
-
- There are more pages in this discussion • 22,838 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.33 |
Change
0.085(6.83%) |
Mkt cap ! $1.575B |
Open | High | Low | Value | Volume |
$1.27 | $1.40 | $1.27 | $12.75M | 9.481M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 6195 | $1.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.33 | 15298 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 55983 | 1.310 |
13 | 55909 | 1.305 |
13 | 66102 | 1.300 |
8 | 146770 | 1.295 |
5 | 384737 | 1.290 |
Price($) | Vol. | No. |
---|---|---|
1.320 | 25076 | 11 |
1.325 | 47597 | 8 |
1.330 | 68719 | 10 |
1.335 | 111450 | 3 |
1.340 | 21600 | 4 |
Last trade - 13.37pm 03/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |